Supporting Information
© Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2006

1
© Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2006

Supporting Information
for

Structure­Activity Studies Within a Family of -Hairpin Protein Epitope Mimetics Inhibiting the p53-HDM2 Protein-Protein Interaction
Rudi Fasan, Ricardo L. A. Dias, Kerstin Moehle, Oliver Zerbe, Daniel Obrecht, Peer R. E. Mittl, Markus G. Grütter, and John A. Robinson*

Contents: 1. Solution NMR of mimetic 1 2. Chemical shift mapping experiments 3. Solution NMR of mimetic 63 4. Experimental details

1. Solution NMR of mimetic 1 The amide NH region of the 1H NMR spectrum of mimetic 1 is shown below (Figure S1), together with chemical shift assignments (Table S1), and distance restraints derived from ROESY spectra (Table S2).

2

Figure S1. NH region of 600 MHz 1H NMR spectrum and 3J HN-H coupling constants of mimetic 1, Bruker DRX-600, H2O/D2O (9:1), pH 5, 300K

Table S1. Chemical shift assignments.
Residue Phe1 Leu2 Trp3 Leu4 Asn5 Lys6 Glu7 Thr8 DPro9 Pro10 NH 7.70 8.26 8.34 8.58 8.45 8.01 8.85 8.74 H-C() 4.70 4.72 4.92 3.76 4.32 4.58 4.58 4.73 4.44 4.37 H-C() 2.83,2.83 1.53, 1.57 3.17, 3.28 1.36, 1.53 2.91, 3.01 1.81, 1.90 1.99, 2.07 4.13 1.83, 2.21 1.60, 1.93 Others H() 7.17, 7.17; H() 7.30, 7.30; H() 7.23 CH() 1.45; CH3() 0.80, 0.80 H( 1) 10.21; H( 1 ) 7.23; H( 3 ) 7.73; H(3 ) 7.17; H(2 ) 7.17; H(2 ) 7.39 CH() 0.72; CH3() 0.59, 0.72 NH() 6.85; NH() 7.53 CH2() 1.42, 1.42; CH2() 1.71, 1.71; CH2() 3.02, 3.02; NH3 +() CH2() 2.30, 2.30 CH3() 1.24 CH2() 1.98, 2.13; CH2() 3.52, 3.81 CH2() 0.95, 1.65; CH2() 3.35, 3.49

Table-S2. Distance restraints derived from 1H,1H-ROE connectivities for mimetic 1 used for simulated annealing calculations with DYANA.
Intraresidual NOE upperdistance limits [Å]
2 LEU 2 LEU 2 LEU 2 LEU 3 TRP 3 TRP 3 TRP 3 TRP 3 TRP 4 LEU 4 LEU 4 LEU 4 LEU 4 LEU 4 LEU HN HN HN HA HN HA HA HB QB HN HN HA HA HA QB 2 LEU HB2 2 LEU HG 2 LEU QQD 2 LEU QD1 3 TRP QB 3 TRP HD1 3 TRP HE3 3 TRP HE3 3 TRP HZ3 4 LEU HG 4 LEU QQD 4 LEU QD1 4 LEU QD2 4 LEU QQD 4 LEU HG 3.42 4.20 7.63 5.35 3.87 4.72 4.50 3.98 5.92 4.69 8.04 4.98 4.98 4.32 2.68

Sequential NOE upper-distance limits [Å]
1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 2 LEU 2 LEU 3 TRP HN 2 LEU QQD HN 10 PRO HA HN 10 PRO QD QD 2 LEU QQD QD 10 PRO HA QD 10 PRO QB QD 10 PRO HG QD 10 PRO QD QE 2 LEU QQD QE 10 PRO HA QE 10 PRO QG QE 10 PRO QD HB 3 TRP HD1 QQD 3 TRP HN HD1 4 LEU QB 7.63 3.11 5.09 9.75 7.62 7.33 7.28 7.52 9.75 7.80 8.29 8.52 4.85 7.63 6.38

Medium and long range noe upper-distance limits [Å]
1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 1 PHE 2 LEU 2 LEU 2 LEU 2 LEU 2 LEU QB QB QB QD QD QD QD QE QE QE QB HG QD1 QD1 QD2 3 TRP HD1 3 TRP HE1 8 THR HB 3 TRP QB 8 THR HB 8 THR QG2 9 DPR QG 3 TRP QB 3 TRP HE3 8 THR QG2 5 ASN HA 5 ASN HA 5 ASN HA 7 GLU- QG 5 ASN HA 6.38 6.38 5.14 8.50 6.41 7.29 8.51 8.41 6.32 8.28 5.17 3.86 6.09 7.40 6.09

3
5 ASN HN 5 ASN HN 5 ASN HA 5 ASN HA 6 LYS+ HN 6 LYS+ HN 6 LYS+ HN 6 LYS+ HA 6 LYS+ QB 7 GLU- HN 7 GLU- HN 7 GLU- HN 8 THR HN 5 ASN HA 5 ASN QB 5 ASN HB 5 ASN QB 6 LYS+ HB 6 LYS+ QB 6 LYS+ QG 6 LYS+ QD 6 LYS+ QE 7 GLU- HB 7 GLU- QB 7 GLU- QG 8 THR HB 2.80 3.91 2.93 2.65 3.42 3.14 5.45 5.94 5.39 3.48 3.20 5.69 3.30 3 TRP HD1 3 TRP HD1 3 TRP HE3 3 TRP HE1 3 TRP HZ2 3 TRP HZ2 3 TRP HH2 3 TRP HH2 4 LEU HA 4 LEU HB 5 ASN HN 5 ASN HA 5 ASN QB 6 LYS+ HA 6 LYS+ QB 7 GLU- HA 8 THR HA 8 THR HA 8 THR HB 8 THR QG2 8 THR QG2 9 DPR HA 9 DPR HA 4 LEU QD 5.81 4 LEU QQD 5.02 4 LEU QQD 7.94 4 LEU HG 4.79 4 LEU QD 6.53 4 LEU QQD 5.87 4 LEU QD 5.94 4 LEU QQD 5.43 5 ASN HN 3.14 5 ASN HN 3.45 6 LYS+ HN 3.89 6 LYS+ HN 3.05 6 LYS+ HN 4.55 7 GLU- HN 3.02 7 GLU- HN 4.70 8 THR HN 3.05 9 DPR HD 3.27 9 DPR QD 2.89 9 DPR QD 6.27 9 DPR HA 6.53 9 DPR QD 7.42 10 PRO HD 3.58 10 PRO QD 3.32 2 LEU QD2 7 GLU- QG 2 LEU QQD 5 ASN HN 2 LEU QQD 5 ASN HA 2 LEU QQD 6 LYS+ HN 2 LEU QQD 6 LYS+ HA 2 LEU QQD 7 GLU- HN 2 LEU QQD 7 GLU- HA 2 LEU QQD 7 GLU- QG 3 TRP HD1 8 THR HB 3 TRP HD1 8 THR QG2 3 TRP HZ3 6 LYS+ QE 3 TRP HZ2 8 THR QG2 7 GLU- QG 9 DPR QD 7.40 7.63 5.78 7.63 8.10 7.63 7.51 8.51 5.50 5.29 6.38 6.47 6.65

2. Chemical shift mapping experiments Table S3. Chemical shift perturbations observed in 500 MHz [15N,1H]-HSQC spectra of 15N-labeled HDM2 upon addition of peptide 5 and mimetics 1, 25, 67 and 78A; and those observed in 900 MHz spectra for the HDM2/78A complex.
HDM2 residue 26 27 28 29 33 34 35 37 38 39 40 41 42 43 44 45 47 48 49 50 51 52 53 54 55 56 57 peptide 5  [ppm] 0.000 0.271 1.007 0.111 0.084 ND 0.092 0.118 ND 0.048 0.088 0.156 0.063 0.114 0.147 0.278 0.054 0.246 0.110 0.000 0.252 0.137 0.047 0.087 0.136 ND 0.202 mimetic 1  [ppm] 0.083 0.025 0.154 0.033 0.000 0.000 0.047 0.041 0.075 0.000 0.000 0.057 0.000 0.046 0.000 0.200 0.000 0.018 0.051 0.000 0.000 0.138 0.102 0.028 0.080 0.090 0.042 mimetic 25  [ppm] 0.162 0.043 0.346 0.070 0.058 0.086 0.064 0.062 0.099 ND 0.000 0.084 0.036 0.032 0.014 0.178 0.048 0.028 0.097 0.000 0.000* 0.292 0.137 ND 0.154 0.242 0.113 mimetic 67  [ppm] 0.266 0.107 0.293 0.146 0.097 0.073 0.021 0.000 0.142 0.359 0.087 0.145 0.150 0.073 0.056 0.082 0.239 ND 0.066 0.000 ND 0.305 ND ND 0.155 0.000 0.245 78A  [ppm] 0.248 0.094 0.452 0.121 0.119 0.167 0.000 0.080 0.186 0.400 0.066 0.219 0.170 0.123 0.037 0.102 0.221 ND 0.050 0.000 ND 0.343 ND ND ND ND 0.260 78A 900 MHz  [ppm] 0.227 0.081 0.388 0.112 0.120 0.118 0.015 0.073 0.178 0.249 0.357 0.200 0.178 0.112 0.027 0.096 0.194 0.410 0.051 0.050 0.349 0.440 0.458 0.564 0.223 0.463 0.244

4
58 59 60 61 62 63 65 66 67 68 69 70 71 72 74 75 76 77 82 83 84 85 86 87 88 90 91 92 93 94 95 99 100 101 102 104 107 108 110 0.301 0.253 0.181 0.109 ND 0.293 0.000 0.098 0.165 0.080 0.062 0.103 0.161 0.185 ND 0.324 0.144 0.187 0.090 0.167 0.073 0.068 0.109 0.108 0.040 0.127 0.156 0.152 0.320 0.165 ND 0.122 0.104 0.162 ND 0.105 0.210 0.164 0.105 ND ND 0.142 0.037 ND 0.323 ND ND ND 0.057 0.117 0.054 ND 0.430 0.106 0.137 0.139 0.123 0.042 0.127 0.030 0.047 0.037 0.064 0.000 0.055 0.202 0.040 ND 0.102 0.110 0.130 ND 0.194 0.079 0.038 0.054 0.099 0.063 ND ND ND 0.026 ND 0.435 0.230 ND ND 0.097 ND ND ND 0.385 0.109 0.168 0.137 0.000 0.049 0.158 0.070 0.062 0.000 0.062 0.000 0.052 0.241 0.060 ND 0.148 0.081 0.105 ND 0.141 0.095 0.012 0.049 0.083 0.106 ND ND ND 0.041 ND 0.175 0.259 ND ND 0.021 0.084 ND 0.066 ND ND ND 0.093 0.050 0.091 0.125 0.041 0.191 0.122 0.224 0.026 0.115 0.168 0.036 ND 0.000 0.165 0.065 ND 0.324 0.202 0.208 0.063 0.197 0.204 ND ND ND 0.045 ND ND ND ND ND 0.050 0.024 ND 0.085 ND ND ND 0.143 0.000 0.177 0.091 0.073 0.226 0.000 0.203 0.000 0.102 0.129 0.159 ND 0.000 0.043 0.109 ND 0.174 0.185 0.041 0.107 0.229 0.249 0.951 0.310 0.385 0.023 0.396 0.551 0.122 0.232 0.000* 0.076 0.035 0.000* 0.149 0.323 0.283 0.288 0.163 0.000 0.166 0.093 0.000 0.226 0.144 0.201 0.000 0.085 0.118 0.158 0.497 0.000 0.039 0.135 0.428 0.163 0.241 0.040 0.102 0.131 0.251

Grey box = disappearance of cross-peak in 2D spectrum and entered as ND. Weighted resonance shift ? {( 1H)2 + 0.2·( 15N)2}0.5. * = peak not detected. The data are also = shown in Figures S2 and S3.

5

Figure S2. Chemical shift perturbations for HDM2 17-125 in complex with peptide 5 (top), mimetic 1 (middle), and mimetic 25 (bottom). The topological representation of the secondary structural elements was adopted from the HDM2/p53 15-29 crystal structure (1YCR). The amide resonances showing a greatly reduced intensity upon ligand addition are given an arbitrary value of  = 0.22 ppm and are indicated with a star.

6

Figure S3. Top: Chemical shift perturbations for HDM2 1 7-125 in complex with mimetic 67 based on 600 MHz HSQC spectra. The amide resonances that show intensity decrease upon addition of the ligand are given an arbitrary value of  = 0.22 ppm and are indicated with a star. Bottom: Chemical shift perturbations for HDM2 17-125 in complex with mimetic 78A based on 900 MHz HSQC spectra. The stars indicate the amide resonances that show an intensity decrease in the 600 MHz HSQC spectrum.

7 3. Solution NMR of mimetic 63

Figure S4. NH region of the 600 MHz 1D 1H NMR spectrum of mimetic 63 in [D6]DMSO, 300 K; chemical shift assignments are given in Table S4.

Table S4. Chemical shift assignments for 63. Residue Phe 1 Glu2 Trp3 Leu4 Asn5 Phe 6 Glu7 Tyr8 9 DPro Pro10 NH 7.56 8.79 8.42 8.69 8.17 7.80 8.65 8.50 H-C() 4.79 4.92 4.66 3.52 4.30 4.74 4.83 4.81 4.45 4.23 H-C() 2.96, 3.11 1.76, 1.87 2.97, 3.22 1.44, 1.68 2.55, 2.68 2.85, 3.08 1.83, 1.83 2.71, 2.97 1.76, 2.03 1.56, 1.75 Others H() 7.43, 7.43; H() 7.32, 7.32; H() CH() 2.21, 2.21 H( 1 ) 10.78; H( 1 ) 7.08; H( 3 ) 7.66; H(3 ) 6.93; H(2 ) 7.22; H(2 ) 7.22 CH() 1.19; CH3() 0.73, 0.74 NH() 6.79; NH() 7.29 H() 7.25, 7.25; H() 7.16, 7.16; H() CH2() 2.22, 2.22 H() 7.04, 7.04; H() 6.70, 6.70 CH2() 1.67, 2.02; CH2() 3.28, 3.41 CH2() 0.77, 1.54; CH2() 3.44, 3.69

Table-S5. Distance restraints for 63, derived from 1H,1H-ROE connectivities, and used for structure calculations with DYANA.
Intraresidual NOE upperdistance limits [Å]
1 PHE HN 1 PHE HN 1 PHE HA 2 GLU- HN 2 GLU- HN 2 GLU- HN 3 TRP HN 3 TRP HN 3 TRP HN 3 TRP HA 3 TRP HA 1 PHE HA 2.90 1 PHE QB 3.41 1 PHE QE 5.85 2 GLU- HB 3.73 2 GLU- QB 3.52 2 GLU- QG 6.28 3 TRP QB 3.79 3 TRP HD1 4.76 3 TRP HE3 4.60 3 TRP HB 3.02 3 TRP HE3 2.93

Sequential NOE upper-distance limits [Å]
1 PHE HN 1 PHE HN 1 PHE HN 1 PHE HA 1 PHE QD 1 PHE QD 1 PHE QD 1 PHE QD 1 PHE QE 1 PHE QE 2 GLU- HN 10 PRO HA 10 P RO QG 10 PRO QD 2 GLU- HN 10 PRO HA 10 PRO QB 10 PRO QG 10 PRO QD 10 PRO QG 10 PRO QD 3 TRP HD1 3.30 5.49 4.29 2.46 7.62 8.51 8.08 7.03 8.08 7.40 5.50

Medium and long range NOE upper-distance limits [Å]
1 PHE HN 1 PHE HN 1 PHE HN 1 PHE HB 1 PHE QB 1 PHE QD 1 PHE QD 1 PHE QD 1 PHE QE 2 GLU- HA 2 GLU- HA 7 GLU- QG 8 TYR HN 9 DPR HA 3 TRP HE1 8 TYR HN 8 TYR QD 8 TYR QE 9 DPR HA 8 TYR QE 6 PHE QD 7 GLU- HA 6.38 3.83 3.80 # 5.50 5.97 9.76 9.75 7.62 9.75 7.62 3.11

8
3 TRP HB3 3 TRP QB 4 LEU HN 4 LEU HN 4 LEU HN 4 LEU HN 4 LEU HA 5 ASN HN 5 ASN HN 5 ASN HA 5 ASN HA 6 PHE HN 6 PHE HN 6 PHE HN 6 PHE HA 7 GLU- HN 8 TYR HN 8 TYR HN 8 TYR HA 3 TRP HE3 3 TRP HD1 4 LEU HA 4 LEU QB 4 LEU HG 4 LEU QQD 4 LEU HG 5 ASN HA 5 ASN HB 5 ASN HB3 5 ASN HD2 6 PHE HA 6 PHE QB 6 PHE QE 6 PHE HB 7 GLU- QG 8 TYR QB 8 TYR QE 8 TYR HB 3.39 3.58 2.65 3.77 3.95 7.63 3.89 2.49 3.48 2.83 5.50 2.93 3.46 7.25 2.99 5.79 3.28 7.63 2.83 2 GLU- HN 2 GLU- HA 2 GLU- QB 2 GLU- QG 2 GLU- QG 3 TRP HA 3 TRP QB 3 TRP HD1 3 TRP HD1 4 LEU HN 4 LEU HA 4 LEU HG 5 ASN HN 5 ASN HN 5 ASN HA 5 ASN HB3 6 PHE HN 6 PHE HA 7 GLU- HN 7 GLU- QG 8 TYR HN 8 TYR HA 8 TYR HA 8 TYR QD 8 TYR QD 8 TYR QE 9 DPR HA 9 DPR HA 3 TRP HE3 3 TRP HN 3 TRP HA 3 TRP HN 3 TRP HA 4 LEU HN 4 LEU HN 4 LEU HN 4 LEU QQD 5 ASN HN 5 ASN HN 5 ASN HN 6 PHE HN 6 PHE QD 6 PHE HN 6 PHE HN 7 GLU- QG 7 GLU- HN 8 TYR HN 8 TYR HN 9 DPR QD 9 DPR HD 9 DPR QD 9 DPR HA 9 DPR QD 9 DPR QD 10 PRO HD 10 PRO QD 5.50 2.71 5.17 6.38 6.38 2.80 4.49 5.34 6.67 4.82 2.90 5.50 2.93 7.62 3.02 4.45 6.38 2.59 3.79 6.38 4.00 3.02 2.67 7.58 7.73 8.53 2.56 2.31 2 GLU- HA 2 GLU- HA 2 GLU- QG 3 TRP HN 3 TRP HN 3 TRP HN 3 TRP QB 3 TRP QB 3 TRP HD1 3 TRP HD1 3 TRP HD1 3 TRP HD1 3 TRP HE3 3 TRP HZ2 4 LEU HA 4 LEU HB 4 LEU HB2 4 LEU QB 4 LEU QQD 6 PHE HB 6 PHE HB 6 PHE QD 6 PHE QE 7 GLU- QB 7 GLU- QG 8 TYR QD 8 TYR QE 8 TYR QD 7.64 8 TYR QE 7.63 5 ASN HA 6.38 6 PHE HN 3.64 6 PHE QB 5.69 8 TYR QE 7.63 8 TYR QD 8.52 8 TYR QE 8.51 6 PHE HN 5.44 6 PHE HB 4.54 6 PHE QB 4.36 8 TYR QB 6.00 6 PHE QB 5.80 10 PRO QD 6.36 6 PHE HN 5.16 6 PHE QD 7.62 6 PHE QE 7.62 6 PHE HN 5.26 6 PHE QE 9.75 8 TYR QD 7.64 8 TYR QE 7.63 8 TYR HB 7.00 8 TYR HB 7.59 9 DPR QD 6.68 9 DPR QD 6.50 10 PRO QD 8.53 10 PRO QD 8.53

4. Experimental
15 NMR studies. For [ N,1H]-HSQC NMR measurements HDM2 was 15

N-labeled by

growing the cells on M9 minimal medium supplemented with

15

N-ammonium chlo-

ride. The HDM2 protein with the His6 tag was dialyzed against 20mM TRIS, 1mM EDTA, 1mM DTT, 0.02 % NaN3, 150mM sodium chloride, pH 7.3 and concentrated in an Amicon Centriplus YM10 until a concentration of 0.3mM was reached, and used directly for NMR studies. Chemical shift mapping was performed using [15 N,1H]HSQC experiments recorded on a BRUKER DRX 500/600 and AV 900 MHz spectrometer at 298K in the absence and presence of the ligands, respectively. Cross15 peaks in [ N,1H]-HSQC spectra of human HDM2 were assigned using published

data [1] and data evaluated as reported previously.[2] Assignments for residues 17-19, 21-25, 31, 36, 46, 78-81, 97, 103, 105, 106, 112-116 were not available. Synthesis. The library of cyclic peptidomimetics was synthesized and purified by preparative HPLC as described. Purity was >95% by analytical HPLC and high field 1H NMR after purification, and the molecular mass was confirmed by mass spectroscopy (HPLC instrument interfaced with a Finnigan AQA electrospray ionization (ESI) mass spectrometer). These data are listed below.

9 Mimetic
f1 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

Sequence
pPFLWLNKET pPFLWLNKEI pPFIWLNKET pPFIWLNKEI pPFIWLNKPT pPFIWLNKPI pPFIWLKKPI pPFLWLGKET pPFLWLGKEI pPFIWLGKET pPFIWLGKEI pPFIWLGKPT pPFIWLGKPI pPFLWLNGET pPFLWLKGEI pPFIWLKGET pPFIWLKGEI pPFIWLKGPT pPFIWLKGPI pPFCWLNKCT pPFLWLNYET pPFKWLNYET pPFEWLNYKT pPFKWLNYEF pPFKWLNYEY pPFKWLNYEB pPFKWLNFET pPFKWLNBET pPFLWGNYET pPFLWNGYET pPFLWNPYET pPFLWPNYET pPFLWVNYET pPFKWNGYEF pPFKBNGYET pPBKWNGYET pPWKFNGYET pPFLWLGKPI pPFLWLNYPI pPFLWLNFPI pPFLWLGFPI pPFLWLNKPI pPFEWLGKPI pPFEWLNWPI pPFEWLNFPI pPFEWLGFPI pPFEWLNYKF pPFEWLNFKY pPFEWLNFKW pPFEWLGFKY pPFEWPNFKY pPFEWLNWKY pPFEWLNHKY

Exact mass (M)
1225.65 1237.69 1225.65 1237.69 1193.66 1205.69 1219.75 1168.63 1180.66 1168.63 1180.66 1136.64 1148.67 1154.58 1180.66 1168.63 1180.66 1136.64 1148.67 1187.54 1260.62 1275.63 1275.63 1321.65 1337.64 1397.68 1259.63 1335.67 1204.56 1204.56 1244.59 1244.59 1246.60 1265.59 1256.59 1295.60 1219.57 1248.67 1240.66 1224.67 1167.65 1205.69 1164.63 1279.64 1240.63 1183.61 1321.65 1321.65 1344.67 1264.63 1305.62 1360.66 1311.64

Measured mass [M+H]+ (m/z)
1226.8 1239.0 1227.0 1239.0 1194.8 1207.0 1221.1 1170.1 1182.0 1170.1 1182.0 1138.1 1150.2 1155.8 1182.1 1170.1 1182.1 1138.0 1150.1 1189.0 1261.8 1276.9 1276.9 1322.8 1339.7 1399.4 1260.9 1336.8 1206.0 1206.0 1245.8 1246.0 1248.0 1267.0 1257.7 1297.0 1220.9 1150.0 1241.7 1225.7 1168.7 1206.6 1165.7 1280.5 1241.6 1185.0 1323.0 1323.0 1346.4 1265.5 1306.5 1362.2 1313.0

10
58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77A 77B 78A = 2 78B pPFEWDQFKY pPFEWDQFPI pPFDWLNFKY pPFQWLNFKY pPFEWLNFRY pPFEWLNFEY pPFEWLNFQY pPFQWLNFQY pPFDWLNFQY pPFEWLNWEF pPFDWLNFEY pPFEWLNWEY pPFEW(NIP)NFEY pPFEWLDWEF pPFEWDQWEF pPFEW(NIB)DWEF pPBEWLDWEF pPFEBLDWEF pPFEwLNWEF pPFE((6Cl]W)LNWEF pPFE((6Cl]W)LNWEF pPFE((6Cl]W)LDWEF pPFE((6Cl]W)LDWEF 1337.61 1256.59 1307.63 1320.67 1349.66 1322.60 1321.61 1320.63 1307.60 1345.61 1308.58 1361.61 1337.48 1346.60 1361.57 1362.63 1422.63 1383.62 1345.61 1379.57 1379.57 1380.56 1380.56 1339.0 1258.0 1309.0 1321.5 1351.0 1324.1 1322.3 1321.6 1308.6 1346.6 1310.4 1363.0 1338.3 1347.3 1362.1 1362.0 1424.2 1385.1 1346.3 1380.1 1380.2 1381.4 1381.2

Note, 78A is identical to 2 in Figure 1B. The standard single letter code is used for proteinogenic amino acids. w = D -tryptophan, (6Cl]W = D or L-6-chlorotryptophan, NIP = N-(3-methylbutyl)glycine (N-isopentylglycine), NIB = N-(2-methylpropyl)glycine (Nisobutylglycine), B = L -biphenylalanine (4-phenyl-L -Phe) . _______________ References (1) Stoll, R.; Renner, C.; Mühlhahn, P.; Hansen, S.; Schumacher, R.; Hesse, F.; Kaluza, B.; Engh, R. A.; Voelter, W.; Holak, T. A. Sequence-specific 1H, 15 N, and 13C assignment of the N-terminal domain of the human oncoprotein MDM2 that binds to p53. J. Biomol. NMR 2000, 17, 91-92. (2) Fasan, R.; Dias, R. L. A.; Moehle, K.; Zerbe, O.; Vrijbloed, J. W.; Obrecht, D.; Robinson, J. A. Using a -hairpin to mimic an -helix: Cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction. Angew. Chem. Int. Ed. 2004, 43, 2109-2112.

